Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 7:12:791983.
doi: 10.3389/fimmu.2021.791983. eCollection 2021.

Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015-16 and 2018-19

Mei Zhang  1 , Xiaoxia Zhu  2 , Jing Wu  1 , Zhengjing Huang  1 , Zhenping Zhao  1 , Xiao Zhang  1 , Yu Xue  2 , Weiguo Wan  2 , Chun Li  1 , Wenrong Zhang  1 , Linhong Wang  1 , Maigeng Zhou  1 , Hejian Zou  2 , Limin Wang  1
Affiliations

Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015-16 and 2018-19

Mei Zhang et al. Front Immunol. .

Abstract

Objective: To determine the nationwide prevalence of hyperuricemia in China and evaluate its trends and associated risk factors.

Methods: Using a multi-stage, stratified, cluster-randomized sampling design, two cross-sectional surveys (representative of national and provincial information) were conducted in 31 provinces (autonomous regions and municipalities) in mainland China, with 166, 861 Chinese adults in 2015-16 and 168, 351 in 2018-19. Serum uric acid (SUA) levels of all participants were measured after a >10-hour overnight fast. Hyperuricemia (HUA) was defined when SUA was >420 μmol/L. Prevalence estimates were weighted to represent the total population considering the complex sampling design. Multivariable logistic regression models was used to estimate factors associated with HUA.

Results: The overall hyperuricemia prevalence in the Chinese adult population was 11.1% (95% confidence interval 10.3% to 11.8%) in 2015-16 and 14.0% (13.1% to 14.8%) in 2018-19; an alarming rise was observed in the three years. Hyperuricemia was more common in men with 19.3% (17.9% to 20.7%) in 2015-16 and 24.4% (23.0% to 25.8%) in 2018-19, although the prevalence also escalated from 2.8% (2.5% to 3.0%) in 2015-16 to 3.6% (3.2% to 4.0%) in 2018-19 in women. The hyperuricemia risk factors include the urban culture, settlement in the East, Zhuang descent, high education, heavy or frequent beer drinking, high red meat intake, physical inactivity, high body mass index, central obesity, hypertension, hyperlipidemia, and low glomerular filtration rate.

Conclusion: The estimated hyperuricemia prevalence among Chinese adults was 14.0% in 2018-19; significant escalating trends were observed between 2015-16 and 2018-19.

Keywords: Chinese; gout; hypeuricemia; prevalence; trends.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of study sample.
Figure 2
Figure 2
Geographic distribution of hyperuricemia prevalence in 2018–19 and changes from 2015–16 to 2018–19.
Figure 3
Figure 3
Risk factors associated with hyperuricemia among adults in mainland China.
See this image and copyright information in PMC

References

    1. Dehlin M, Jacobsson L, Roddy E. Global Epidemiology of Gout: Prevalence, Incidence, Treatment Patterns and Risk Factors. Nat Rev Rheumatol (2020) 16(7):380–90. doi: 10.1038/s41584-020-0441-1 - DOI - PubMed
    1. Choi HK, Mount DB, Reginato AM. Pathogenesis of Gout. Ann Intern Med (2005) 143(7):499–516. doi: 10.7326/0003-4819-143-7-200510040-00009 - DOI - PubMed
    1. Badve SV, Brown F, Hawley CM, Johnson DW, Kanellis J, Rangan GK, et al. . Challenges of Conducting a Trial of Uric-Acid-Lowering Therapy in CKD. Nat Rev Nephrol (2011) 7(5):295–300. doi: 10.1038/nrneph.2010.186 - DOI - PubMed
    1. Jalal DI, Chonchol M, Chen W, Targher G. Uric Acid as a Target of Therapy in CKD. Am J Kidney Dis (2013) 61(1):134–46. doi: 10.1053/j.ajkd.2012.07.021 - DOI - PMC - PubMed
    1. Puddu PE, Bilancio G, Terradura Vagnarelli O, Lombardi C, Mancini M, Zanchetti A, et al. . Serum Uric Acid and Egfr_CKDEPI Differently Predict Long-Term Cardiovascular Events and All Causes of Deaths in a Residential Cohort. Int J Cardiol (2014) 171(3):361–7. doi: 10.1016/j.ijcard.2013.12.029 - DOI - PubMed

Publication types